Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lingao Ju

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
Cancer Cell International|August 31, 2021
The cholesterol esterification inhibitor avasimibe suppresses tumour proliferation and metastasis via the E2F-1 signalling pathway in prostate cancerKangping Xiong, Gang Wang, Tianchen Peng, et al.
Nature Biotechnology|May 9, 2024
Tracking single-cell evolution using clock-like chromatin accessibility lociYu Xiao, Wan Jin, Lingao Ju, et al.
Journal of Cellular and Molecular Medicine|December 11, 2019
Inhibition of MELK produces potential anti-tumour effects in bladder cancer by inducing G1/S cell cycle arrest via the ATM/CHK2/p53 pathwaySong Chen, Qiang Zhou, Zicheng Guo, et al.
Genes & Diseases|January 22, 2026
Epigenetic insights into minimal residual disease detection in cancerLingao Ju, Gang Wang, Zilin Xu, et al.
Scientific Reports|October 26, 2016
Simvastatin induces cell cycle arrest and inhibits proliferation of bladder cancer cells via PPARγ signalling pathwayGang Wang, Rui Cao, Yongzhi Wang, et al.
Theranostics|February 24, 2025
DLGAP5 enhances bladder cancer chemoresistance by regulating glycolysis through MYC stabilizationZhao Deng, Fenfang Zhou, Mingxing Li, et al.
Oncogene|January 5, 2024
DLGAP5 triggers proliferation and metastasis of bladder cancer by stabilizing E2F1 via USP11Fenfang Zhou, Zhao Deng, Dexin Shen, et al.
Clinical and Translational Medicine|December 28, 2024
Concurrent DNA hypomethylation and epigenomic reprogramming driven by androgen receptor binding in bladder cancer oncogenesisYu Xiao, Lingao Ju, Wan Jin, et al.
Oncotargets and Therapy|September 18, 2020
TRPM8 Inhibition Regulates the Proliferation, Migration and ROS Metabolism of Bladder Cancer CellsGang Wang, Rui Cao, Kaiyu Qian, et al.
Oncogene|September 26, 2020
A novel germline EGFR variant p.R831H causes predisposition to familial CDK12-mutant prostate cancer with tandem duplicator phenotypeKaiyu Qian, Gang Wang, Lingao Ju, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Cancer Cell International|August 31, 2021
The cholesterol esterification inhibitor avasimibe suppresses tumour proliferation and metastasis via the E2F-1 signalling pathway in prostate cancerKangping Xiong, Gang Wang, Tianchen Peng, et al.
Nature Biotechnology|May 9, 2024
Tracking single-cell evolution using clock-like chromatin accessibility lociYu Xiao, Wan Jin, Lingao Ju, et al.
Journal of Cellular and Molecular Medicine|December 11, 2019
Inhibition of MELK produces potential anti-tumour effects in bladder cancer by inducing G1/S cell cycle arrest via the ATM/CHK2/p53 pathwaySong Chen, Qiang Zhou, Zicheng Guo, et al.
Genes & Diseases|January 22, 2026
Epigenetic insights into minimal residual disease detection in cancerLingao Ju, Gang Wang, Zilin Xu, et al.
Scientific Reports|October 26, 2016
Simvastatin induces cell cycle arrest and inhibits proliferation of bladder cancer cells via PPARγ signalling pathwayGang Wang, Rui Cao, Yongzhi Wang, et al.
Theranostics|February 24, 2025
DLGAP5 enhances bladder cancer chemoresistance by regulating glycolysis through MYC stabilizationZhao Deng, Fenfang Zhou, Mingxing Li, et al.
Oncogene|January 5, 2024
DLGAP5 triggers proliferation and metastasis of bladder cancer by stabilizing E2F1 via USP11Fenfang Zhou, Zhao Deng, Dexin Shen, et al.
Clinical and Translational Medicine|December 28, 2024
Concurrent DNA hypomethylation and epigenomic reprogramming driven by androgen receptor binding in bladder cancer oncogenesisYu Xiao, Lingao Ju, Wan Jin, et al.
Oncotargets and Therapy|September 18, 2020
TRPM8 Inhibition Regulates the Proliferation, Migration and ROS Metabolism of Bladder Cancer CellsGang Wang, Rui Cao, Kaiyu Qian, et al.
Oncogene|September 26, 2020
A novel germline EGFR variant p.R831H causes predisposition to familial CDK12-mutant prostate cancer with tandem duplicator phenotypeKaiyu Qian, Gang Wang, Lingao Ju, et al.
Pageof 8